Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies

Conditions: Tyrosinemia, Type I; Tyrosinemia, Type II; Tyrosinemia, Type III; Alkaptonuria; Homocystine; Metabolic Disorder; MSUD (Maple Syrup Urine Disease) Interventions: Dietary Supplement: Zero minis (range of protein substitutes in tablet form) Sponsors: metaX Institut fuer Diatetik GmbH; Birmingham Women ' s and Children ' s NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials